$3250 | Single User
$4650 | Site License
$5650 | Global License

Hormone Replacement Therapy (HRT) Market, By Replacement Therapy (Estrogen, Human Growth Hormone, Testosterone and Thyroid), By Route of Administration, By Disease, and Geography (NA, EU, APAC, and RoW) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated
[Lowest Price Guaranteed: $3,250]

Published by AnalystView: 01 Jul 2020 | 270561 | In Stock
Related Topics: Abbott , COVID , Drug , Food , Hypogonadism , Menopause , Pfizer

Introduction

REPORT HIGHLIGHT

The Hormone Replacement Therapy (HRT) market is estimated to represent a global market of USD 20.97 billion by 2019 with growth rate of 7.5%.

Market Dynamics

Menopause is a natural and inevitable event, defined as the final menstrual period. It requires a retrospective clinical diagnosis with ethnic and regional variations. Hormone replacement therapies (HRT) such as systemic estrogen (skin patch, gel, or cream) are considered to be the most effective treatment option in the treatment of menopausal night sweats and hot flashes. These therapies also ease vaginal symptoms of menopause such as itching, burning, and dryness. Due to this fact, women undergoing these therapies has increased considerably over the past few years.

As per the Rose Research Survey (April 2014), women accepting HT therapy has increased considerably, from 4.5 million in 2005 to around 5.0 million in 2014. In addition to this, the growth of this market is attributed to the rise in a number of women in menopausal age coupled with growing patient awareness. For example, according to the International Menopause Society, thousands of women reach menopause experience every day. On another hand, the high cost of therapies coupled with the high risk of adverse reactions posing a potential threat to this industry. For example, as per the study published in PLOS One journal in 2014, testosterone therapy in cardiac patients considerably increase the risk of heart attack.

Replacement Therapy Takeaway

In terms of replacement therapy, the market is categorized as Estrogen, Human Growth Hormone, Testosterone and Thyroid. Estrogen replacement therapy recorded USD 9.58 billion and is expected to soar owing to the approval of new products by the United States Food and Drug Association under this category. Some of the recommended estrogen doses for women with Primary Ovarian Insufficiency (POI) are 1.25 mg conjugated equine estrogen (CEE), 17b-estradiol 2 mg/day, and transdermal estradiol 75–100 mg/day.

Furthermore, Climara, Estradot, Divigel, Elestrin, and EstroGel are some of the commercially available transdermal estrogen products in the U.S. and Canada market by various manufacturers. On contrary, thyroid replacement therapy is considered to be the lowest revenue generating segment and is also pegged to register slowest growth rate i.e. 6.9% in terms of value. Levothyroxine (generic form of thyroxine) is a most commonly prescribed thyroid hormone replacement drug across the globe.

Cumulative effect of COVID-19

As players move from reacting to mitigating the impact of the COVID-19 outbreak, they are keenly focusing on Hormone Replacement Therapy (HRT) market offers detailed analysis on the emerging market player during this outbreak. The report also included the detailed study related to impact of COVID-19 on the supply chain based on both downstream and upstream markets. The report also includes the future development in the Hormone Replacement Therapy (HRT) Market in relation with the market impact of COVID-19.

Regional Takeaway

Regionally, the market is divided into North America, Europe, Asia Pacific and Rest of the World. Of these, North America captured the highest share, 41.67% of the total market. Drugs such as Premarin, AndroGel, and Levothyroxine have been recorded to gain the maximum prescription within this region. However, Asia Pacific region represents one of the fastest growing regions, enjoying an annual average growth rate over 9.0%. Rising awareness levels coupled with increasing focus of healthcare and government on eradication of hormonal deficiencies are likely to establish a healthy platform for the industry growth in this region.

Key Vendor Takeaway

Companies such as Novo Nordisk, Amgen, Inc., Abbott, Eli Lily and Genentech are covered under research study. The industry experiences a high level of competition. In such fragmented landscape, key players are actively engaged in strategic collaborations to expand their market presence. For instance, in February 2015, Mylan Laboratories signed an agreement for the acquisition of Famy Care.

This acquisition has helped the company to increase its female health product portfolio inclusive of production of hormone replacement drugs, Intra-Uterine Devices (IUD), and contraceptives. Likewise, in December 2014, Pfizer collaborated with OPKO Health. As per the agreement, OPKO would be developing and marketing long-acting human growth hormone (hGH-CTP) (PF-06836922), whereas Pfizer would take care of the post-market studies and development costs.

The market size and forecast for each segment has been provided for the period 2016 to 2027, considering 2019 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2021 to 2027 for every reported segment.

The years considered for the study are:

Historical Year – 2016 to 2018

Base Year – 2019

Estimated Year – 2020

Projected Year – 2027

The proposed reports analyse and evaluates the COVID-19 impact, and anticipated change on the future market scenario on this industry, by taking into the account the economic, political, technological, and social, parameters.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

HORMONE REPLACEMENT THERAPY (HRT) MARKET, BY REPLACEMENT THERAPY

Estrogen

Human Growth Hormone

Testosterone

Thyroid

HORMONE REPLACEMENT THERAPY (HRT) MARKET, BY ROUTE OF ADMINISTRATION

Parenteral

Oral

Transdermal

Other

HORMONE REPLACEMENT THERAPY (HRT) MARKET, BY DISEASE

Male Hypogonadism

Menopause

Hypothyroidism

Growth Hormone Deficiency

Others

HORMONE REPLACEMENT THERAPY (HRT) MARKET, BY REGION

North America

U.S.

Canada

Europe

Germany

France

Rest of Europe

Asia Pacific

India

China

Rest of APAC

Rest of the World

Middle East and Africa

Latin America

Table of Contents
for Hormone Replacement Therapy (HRT) Market, By Replacement Therapy (Estrogen, Human Growth Hormone, Testosterone and Thyroid), By Route of Administration, By Disease, and Geography (NA, EU, APAC, and RoW) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated

  • TABLE OF CONTENT

    1. HORMONE REPLACEMENT THERAPY (HRT) MARKET OVERVIEW

    1.1. Study Scope

    1.2. Assumption and Methodology

    2. EXECUTIVE SUMMARY

    2.1. Key Market Facts

    2.2. Geographical Scenario

    2.3. Companies in the Market

    3. HORMONE REPLACEMENT THERAPY (HRT) KEY MARKET TRENDS

    3.1. Market Drivers

    3.1.1. Impact Analysis of Market Drivers

    3.2. Market Restraints

    3.2.1. Impact Analysis of Market Restraints

    3.3. Market Opportunities

    3.4. Market Future Trends

    4. HORMONE REPLACEMENT THERAPY (HRT) INDUSTRY STUDY

    4.1. Porter’s Analysis

    4.2. Market Attractiveness Analysis

    4.3. Regulatory Framework Analysis

    4.4 HORMONE REPLACEMENT THERAPY (HRT) MARKET: COVID-19 IMPACT ANALYSIS

    4.4.1 Pre-COVID-19 Impact Analysis

    4.4.2 Post-COVID-19 Impact Analysis

    4.4.3 Top Performing Segments

    4.4.4 Marginal Growth Segments

    4.4.5 Top Looser Segments

    4.4.6 Marginal Loss Segments

    5. HORMONE REPLACEMENT THERAPY (HRT) MARKET LANDSCAPE

    5.1. Market Share Analysis

    6. HORMONE REPLACEMENT THERAPY (HRT) MARKET – BY REPLACEMENT THERAPY

    6.1. Overview

    6.2. Estrogen

    6.2.1. Overview

    6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    6.3. Human Growth Hormone

    6.3.1. Overview

    6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    6.4. Testosterone

    6.4.1. Overview

    6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    6.5. Thyroid

    6.5.1. Overview

    6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    7. HORMONE REPLACEMENT THERAPY (HRT) MARKET – BY ROUTE OF ADMINISTRATION

    7.1. Overview

    7.2. Parenteral

    7.2.1. Overview

    7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    7.3. Oral

    7.3.1. Overview

    7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    7.4. Transdermal

    7.4.1. Overview

    7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    7.5. Other

    7.5.1. Overview

    7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    8. HORMONE REPLACEMENT THERAPY (HRT) MARKET – BY DISEASE

    8.1. Overview

    8.2. Male Hypogonadism

    8.2.1. Overview

    8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    8.3. Menopause

    8.3.1. Overview

    8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    8.4. Hypothyroidism

    8.4.1. Overview

    8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    8.5. Growth Hormone Deficiency

    8.5.1. Overview

    8.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    8.6. Others

    8.6.1. Overview

    8.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    9. HORMONE REPLACEMENT THERAPY (HRT) MARKET– BY GEOGRAPHY

    9.1. Introduction

    9.2. North America

    9.2.1. Overview

    9.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    9.2.3. U.S.

    9.2.3.1. Overview

    9.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    9.2.4. Canada

    9.2.4.1. Overview

    9.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    9.3. Europe

    9.3.1. Overview

    9.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    9.3.3. France

    9.3.3.1. Overview

    9.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    9.3.4. Germany

    9.3.4.1. Overview

    9.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    9.3.5. Rest of Europe

    9.3.5.1. Overview

    9.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    9.4. Asia Pacific (APAC)

    9.4.1. Overview

    9.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    9.4.3. China

    9.4.3.1. Overview

    9.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    9.4.4. India

    9.4.4.1. Overview

    9.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    9.4.5. Rest of APAC

    9.4.5.1. Overview

    9.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    9.5. Rest of the World

    9.5.1. Overview

    9.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    9.5.3. Latin America

    9.5.3.1. Overview

    9.5.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    9.5.4. Middle East and Africa

    9.5.4.1. Overview

    9.5.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    10. KEY VENDOR ANALYSIS

    10.1. Novo Nordisk

    10.1.1. Company Overview

    10.1.2. SWOT Analysis

    10.1.3. Key Developments

    10.2. Amgen, Inc.

    10.2.1. Company Overview

    10.2.2. SWOT Analysis

    10.2.3. Key Developments

    10.3. Abbott

    10.3.1. Company Overview

    10.3.2. SWOT Analysis

    10.3.3. Key Developments

    10.4. Eli Lily & Company

    10.4.1. Company Overview

    10.4.2. SWOT Analysis

    10.4.3. Key Developments

    10.5. Genentech

    10.5.1. Company Overview

    10.5.2. SWOT Analysis

    10.5.3. Key Developments

    11. 360 DEGREE ANALYSTVIEW

    12. APPENDIX

    12.1. Research Methodology

    12.2. Abbreviations

    12.3. Disclaimer

    12.4. Contact Us

List Of Tables
in Hormone Replacement Therapy (HRT) Market, By Replacement Therapy (Estrogen, Human Growth Hormone, Testosterone and Thyroid), By Route of Administration, By Disease, and Geography (NA, EU, APAC, and RoW) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated

List of Tables

Table 1 List of Acronyms

Table 2 Key Market Facts, 2016 – 2027

Table 3 Market Drivers: Impact Analysis

Table 4 Market Restraint: Impact Analysis

Table 5 Market Opportunity: Impact Analysis

Table 6 PEST Analysis

Table 7 Porter’s Five Forces Analysis

Table 8 Company Market Share Analysis

Table 9 Global Hormone Replacement Therapy (HRT) Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Billion)

Table 10 Hormone Replacement Therapy (HRT) Market, by Replacement Therapy, 2016 – 2027 (USD Billion)

Table 11 Hormone Replacement Therapy (HRT) Market, by Route of Administration, 2016 – 2027 (USD Billion)

Table 12 Hormone Replacement Therapy (HRT) Market, by Disease, 2016 – 2027 (USD Billion)

Table 13 Hormone Replacement Therapy (HRT) Market, by Geography, 2016 – 2027 (USD Billion)

Table 14 North America Hormone Replacement Therapy (HRT) Market, 2016 – 2027 (USD Billion)

Table 15 U.S. Hormone Replacement Therapy (HRT) Market, 2016 – 2027 (USD Billion)

Table 16 Canada Hormone Replacement Therapy (HRT) Market, 2016 – 2027 (USD Billion)

Table 17 Europe Hormone Replacement Therapy (HRT) Market, 2016 – 2027 (USD Billion)

Table 18 France Hormone Replacement Therapy (HRT) Market, 2016 – 2027 (USD Billion)

Table 19 Germany Hormone Replacement Therapy (HRT) Market, 2016 – 2027 (USD Billion)

Table 20 Asia Pacific Hormone Replacement Therapy (HRT) Market, 2016 – 2027 (USD Billion)

Table 21 China Hormone Replacement Therapy (HRT) Market, 2016 – 2027 (USD Billion)

Table 22 India Hormone Replacement Therapy (HRT) Market, 2016 – 2027 (USD Billion)

Table 23 Latin America Hormone Replacement Therapy (HRT) Market, 2016 – 2027 (USD Billion)

Table 24 MEA Hormone Replacement Therapy (HRT) Market, 2016 – 2027 (USD Billion)

List Of Figures, Charts and Diagrams
in Hormone Replacement Therapy (HRT) Market, By Replacement Therapy (Estrogen, Human Growth Hormone, Testosterone and Thyroid), By Route of Administration, By Disease, and Geography (NA, EU, APAC, and RoW) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated

List of Figures

Figure 1 Research Methodology

Figure 2 Research Process Flow Chart

Figure 3 Comparative Analysis, by Geography, 2016-2025 (Value %)

Figure 4 Regulatory Framework Analysis

Figure 5 Hormone Replacement Therapy (HRT) Market, by Replacement Therapy, 2016 – 2027 (USD Billion)

Figure 5 Hormone Replacement Therapy (HRT) Market, by Route of Administration, 2016 – 2027 (USD Billion)

Figure 5 Hormone Replacement Therapy (HRT) Market, by Disease, 2016 – 2027 (USD Billion)

Figure 6 Hormone Replacement Therapy (HRT) Market, by Geography, 2016 – 2027 (USD Billion)

Additional Details

Publisher

AnalystView

Publisher Information

AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. Our company is led by a team of passionate, naturally curious, and strategic thinkers from different industry backgrounds.



These experts are dedicated to creating concrete market data analysis in various industries such as Healthcare, Bulk Chemicals, Semiconductors and Electronics, Foods and Beverages. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends.



We aim to be the number one choice for various clients who require credible data to make vital business decisions. We wish to be a trusted and reliable analytics partner to major business organizations.



We understand that critical business decisions can be taken only when verified, authentic information is available. Therefore, our experts work meticulously to provide our clients with the accurate data, so that they need not spend time in verifying it.



It is also our goal to help our clients ignore traditional research methods that require a large amount of capital, manpower, and most important of it all – the time. We know that these factors are precious to a company and always follow the latest research techniques that produce the required result in a short span of time.

Reference

270561 | AV181

Number of Pages

201

Report Format

PDF

AnalystView Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Hormone Sensitive Breast Cancer Global Clinical Trials Review, H1, 2016
Hormone Sensitive Breast Cancer Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical ...
29 Jun 2016 by Global Data USD $2,500 More Info
Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2016
Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinica...
29 Jun 2016 by Global Data USD $2,500 More Info
Hormone Refractory Breast Cancer Global Clinical Trials Review, H1, 2016
Hormone Refractory Breast Cancer Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical...
29 Jun 2016 by Global Data USD $2,500 More Info
Hormone Sensitive Breast Cancer Global Clinical Trials Review, H1, 2016
Hormone Sensitive Breast Cancer Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical ...
29 Jun 2016 by Global Data USD $2,500 More Info
Global Urological Cancer Market to 2022 - Strong Growth Driven by Rising Prevalence, Increased Uptake of Hormone Therapies and Approval of Novel Biologics
Global Urological Cancer Market to 2022 - Strong Growth Driven by Rising Prevalence, Increased Uptak...
16 Jun 2016 by GBI Research USD $4,995 More Info
Global Urological Cancer Market to 2022 - Strong Growth Driven by Rising Prevalence, Increased Uptake of Hormone Therapies and Approval of Novel Biologics
Global Urological Cancer Market to 2022 - Strong Growth Driven by Rising Prevalence, Increased Uptak...
16 Jun 2016 by GBI Research USD $4,995 More Info
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2016
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Tria...
15 Jun 2016 by Global Data USD $2,500 More Info
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2016
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Tria...
15 Jun 2016 by Global Data USD $2,500 More Info
Market Access Impact: Growth Hormone Deficiency (US)
IntroductionGHD: Has one brand found the winning market access strategy in the US?Market barriers af...
01 May 2016 by FirstWord Pharma USD $4,995 More Info
Market Access Impact: Growth Hormone Deficiency (EU5)
IntroductionGHD: Has one brand found the winning market access strategy in Europe?Market barriers af...
01 May 2016 by FirstWord Pharma USD $4,995 More Info

This report is published by AnalystView

AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. Our company is led by a team of passionate, naturally curious, and strategic thinkers from different industry backgrounds.

These experts are dedicated to creating concrete market data analysis in various industries such as Healthcare, Bulk Chemicals, Semiconductors and Electronics, Foods and Beverages. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends.

We aim to be the number one choice for various clients who require credible data to make vital business decisions. We wish to be a trusted and reliable analytics partner to major business organizations.

We understand that critical business decisions can be taken only when verified, authentic information is available. Therefore, our experts work meticulously to provide our clients with the accurate data, so that they need not spend time in verifying it.

It is also our goal to help our clients ignore traditional research methods that require a large amount of capital, manpower, and most important of it all – the time. We know that these factors are precious to a company and always follow the latest research techniques that produce the required result in a short span of time.

Download Free Report Summary PDF

Hormone Replacement Therapy (HRT) Market, By Replacement Therapy (Estrogen, Human Growth Hormone, Testosterone and Thyroid), By Route of Administration, By Disease, and Geography (NA, EU, APAC, and RoW) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...